Results 81 to 90 of about 19,509 (202)
Aim. To compare the efficacy of combinational therapy with added bisoprolol or sotalol, in patients with ventricular rhythm disorders (VRD) via the assessment of regulatory-adaptive status (RAS).Material and methods. Sixty VRD patients with II-III Bigger
V. G. Tregubov +3 more
doaj +1 more source
ABSTRACT Hypertension is a leading chronic disease globally, with rising prevalence in China. A considerable number of hypertension patients struggle to achieve target blood pressure levels with monotherapy alone. The bisoprolol/amlodipine FDC shows promise for blood pressure control and adherence, whereas clinical evidence for Chinese patients is ...
Ning Wang +11 more
wiley +1 more source
Aim. To study a clinical equivalence of two medications of bisoprolol in patients with arterial hypertension (AH) 1-2 grades.Methods. Efficacy and tolerability of original (Concor, NYCOMED, Merck KGaA) and generic (Bisogamma, WORWAG PHARMA GmbH & Co)
S. N. Tolpygina +2 more
doaj +1 more source
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
MIKROENKAPSULASI BISOPROLOL FUMARAT DENGAN ETIL SELULOSA MENGGUNAKAN METODE PENGUAPAN PELARUT
Telah dilakukan penelitian tentang mikroenkapsulasi bisoprolol fumarat dengan penyalut etil selulosa menggunakan metode penguapan pelarut. Mikrokapsul bisoprolol diformulasi dengan perbandingan obat dan polimer 1:1, 1:2 dan 1:3. Penelitian ini bertujuan
Annisa, Khairanis Noveerah
core
ABSTRACT Thymomas are rare epithelial tumors of the anterior mediastinum known for their association with autoimmune and paraneoplastic syndromes, most notably myasthenia gravis (MG). Cardiomyopathy is an exceptionally rare paraneoplastic manifestation.
Manish Barman +5 more
wiley +1 more source
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial [PDF]
Information on the effectiveness of beta-blockade in patients with heart failure (HF) and concomitant renal impairment is scarce and beta-blockers are underutilized in these patients.
Erdmann, E. +15 more
core +1 more source
ABSTRACT This case report describes a 77‐year‐old man with multiple comorbidities, including atrial fibrillation, heart failure with mildly reduced ejection fraction, hypertension, diabetes mellitus, and prior coronary artery bypass grafting, who presented with severe hypertension and dyspnoea.
Reem Fakak +2 more
wiley +1 more source
BACKGROUND Inflammation and oxidative stress play a role in the pathophysiology of chronic heart failure (CHF). Our previous clinical trial, the Bisoprolol Improvement Group for Chronic Heart Failure Treatment Study in Dokkyo Medical University (BRIGHT-D)
Shigeru Toyoda +11 more
semanticscholar +1 more source

